Published by Josh White on 25th June 2026
(Sharecast News) - Avacta said on Thursday it had agreed the design of a pivotal US trial for its lead cancer therapy with the US Food and Drug Administration, while reporting further clinical data that it said strengthened the case for its preCISION oncology platform.
URL: http://www.digitallook.com/dl/news/story/36030271/...